N-Acetylcysteine Enhances the Recovery of Ischemic Limb in Type-2 Diabetic Mice

Critical limb ischemia (CLI) is a severe complication of diabetes mellitus that occurs without effective therapy. Excessive reactive oxygen species (ROS) production and oxidative stress play critical roles in the development of diabetic cardiovascular complications. N-acetylcysteine (NAC) reduces ischemia-induced ROS production. The present study aimed to investigate the effect of NAC on the recovery of ischemic limb in an experimental model of type-2 diabetes. TALLYHO/JngJ diabetic and SWR/J non-diabetic mice were used for developing a CLI model. For NAC treatment, mice received NAC (1 mg/mL) in their drinking water for 24 h before initiating CLI, and continuously for the duration of the experiment. Blood flow, mechanical function, histology, expression of antioxidant enzymes including superoxide dismutase (SOD)-1, SOD-3, glutathione peroxidase (Gpx)-1, catalase, and phosphorylated insulin receptor substrate (IRS)-1, Akt, and eNOS in ischemic limb were evaluated in vivo or ex vivo. Body weight, blood glucose, plasma advanced glycation end-products (AGEs), plasma insulin, insulin resistance index, and plasma TNF-a were also evaluated during the experiment. NAC treatment effectively attenuated ROS production with preserved expressions of SOD-1, Gpx-1, catalase, phosphorylated Akt, and eNOS, and enhanced the recovery of blood flow and function of the diabetic ischemic limb. NAC treatment also significantly decreased the levels of phosphorylated IRS-1 (Ser307) expression and plasma TNF-α in diabetic mice without significant changes in blood glucose and AGEs levels. In conclusion, NAC treatment enhanced the recovery of blood flow and mechanical function in ischemic limbs in T2D mice in association with improved tissue redox/inflammatory status and insulin resistance.

[1]  R. Mittler,et al.  Combination of Antioxidant Enzyme Overexpression and N‐Acetylcysteine Treatment Enhances the Survival of Bone Marrow Mesenchymal Stromal Cells in Ischemic Limb in Mice With Type 2 Diabetes , 2021, Journal of the American Heart Association.

[2]  Z. Giricz,et al.  Natural and synthetic antioxidants targeting cardiac oxidative stress and redox signaling in cardiometabolic diseases. , 2021, Free radical biology & medicine.

[3]  P. Reddy,et al.  Mitochondria-Targeted Small Peptide, SS31 Ameliorates Diabetes Induced Mitochondrial Dynamics in Male TallyHO/JngJ Mice , 2020, Molecular Neurobiology.

[4]  C. Sen,et al.  N-acetylcysteine differentially regulates the populations of bone marrow and circulating endothelial progenitor cells in mice with limb ischemia. , 2020, European journal of pharmacology.

[5]  G. Flaker,et al.  Helicobacter pylori Infection Impairs Endothelial Function Through an Exosome‐Mediated Mechanism , 2020, Journal of the American Heart Association.

[6]  M. Ibrahim,et al.  Redox status, inflammation, necroptosis and inflammasome as indispensable contributors to high fat diet (HFD)-induced neurodegeneration; Effect of N-acetylcysteine (NAC). , 2019, Archives of biochemistry and biophysics.

[7]  Y. Chai,et al.  Advanced Glycation End Products (AGEs) Induce Apoptosis of Fibroblasts by Activation of NLRP3 Inflammasome via Reactive Oxygen Species (ROS) Signaling Pathway , 2019, Medical science monitor : international medical journal of experimental and clinical research.

[8]  A. Moran,et al.  Cystic fibrosis related diabetes: Pathophysiology, screening and diagnosis. , 2019, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[9]  E. Solá,et al.  Relationship between Oxidative Stress, ER Stress, and Inflammation in Type 2 Diabetes: The Battle Continues , 2019, Journal of clinical medicine.

[10]  J. L. La Favor,et al.  Endothelial Dysfunction: Is There a Hyperglycemia-Induced Imbalance of NOX and NOS? , 2019, International journal of molecular sciences.

[11]  Luca Truscello,et al.  Antioxidants protect against diabetes by improving glucose homeostasis in mouse models of inducible insulin resistance and obesity , 2019, Diabetologia.

[12]  Xu Li,et al.  Diabetes Mellitus and Risk of Hepatic Fibrosis/Cirrhosis , 2019, BioMed research international.

[13]  K. Mahaffey,et al.  Cardiovascular and Limb Outcomes in Patients With Diabetes and Peripheral Artery Disease: The EUCLID Trial. , 2018, Journal of the American College of Cardiology.

[14]  Deborah Rolka,et al.  Resurgence of Diabetes-Related Nontraumatic Lower-Extremity Amputation in the Young and Middle-Aged Adult U.S. Population , 2018, Diabetes Care.

[15]  N. Chakfé,et al.  N-Acetyl Cysteine Restores Limb Function, Improves Mitochondrial Respiration, and Reduces Oxidative Stress in a Murine Model of Critical Limb Ischaemia. , 2018, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[16]  F. Tay,et al.  Biological Activities and Potential Oral Applications of N-Acetylcysteine: Progress and Prospects , 2018, Oxidative medicine and cellular longevity.

[17]  Rabia Johnson,et al.  A Systematic Review on the Protective Effect of N-Acetyl Cysteine Against Diabetes-Associated Cardiovascular Complications , 2018, American Journal of Cardiovascular Drugs.

[18]  K. Griendling,et al.  Reactive Oxygen Species in Metabolic and Inflammatory Signaling. , 2018, Circulation research.

[19]  F. Dal-Pizzol,et al.  N-acetylcysteine effects on a murine model of chronic critical limb ischemia. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[20]  M. Akash,et al.  Tumor Necrosis Factor‐Alpha: Role in Development of Insulin Resistance and Pathogenesis of Type 2 Diabetes Mellitus , 2018, Journal of cellular biochemistry.

[21]  Q. Su,et al.  Activation of NLRP3 Inflammasome by Advanced Glycation End Products Promotes Pancreatic Islet Damage , 2017, Oxidative medicine and cellular longevity.

[22]  M. Akash,et al.  Mechanism of Generation of Oxidative Stress and Pathophysiology of Type 2 Diabetes Mellitus: How Are They Interlinked? , 2017, Journal of cellular biochemistry.

[23]  T. Kyriakides,et al.  Redox Signaling in Diabetic Wound Healing Regulates Extracellular Matrix Deposition. , 2017, Antioxidants & redox signaling.

[24]  S. Diamond,et al.  Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi , 2017, Circulation.

[25]  Xia Li,et al.  Inhibition of Methylglyoxal-Induced AGEs/RAGE Expression Contributes to Dermal Protection by N-Acetyl-L-Cysteine , 2017, Cellular Physiology and Biochemistry.

[26]  M. Cooper,et al.  Diabetes and Kidney Disease: Role of Oxidative Stress. , 2016, Antioxidants & redox signaling.

[27]  Qiqi Zhu,et al.  N-acetylcysteine attenuates myocardial dysfunction and postischemic injury by restoring caveolin-3/eNOS signaling in diabetic rats , 2016, Cardiovascular Diabetology.

[28]  Bin Wang,et al.  The protection conferred against ischemia-reperfusion injury in the diabetic brain by N-acetylcysteine is associated with decreased dicarbonyl stress. , 2016, Free radical biology & medicine.

[29]  T. Kietzmann,et al.  Reactive oxygen species and fibrosis: further evidence of a significant liaison , 2016, Cell and Tissue Research.

[30]  J. Ma,et al.  Netrin-1 promotes mesenchymal stem cell revascularization of limb ischaemia , 2016, Diabetes & vascular disease research.

[31]  Jianyi(Jay) Zhang,et al.  Bach1 Induces Endothelial Cell Apoptosis and Cell-Cycle Arrest through ROS Generation , 2016, Oxidative medicine and cellular longevity.

[32]  Zhenguo Liu,et al.  N-acetylcysteine inhibits in vivo oxidation of native low-density lipoprotein , 2015, Scientific Reports.

[33]  T. Pihlajaniemi,et al.  Redox-fibrosis: Impact of TGFβ1 on ROS generators, mediators and functional consequences , 2015, Redox biology.

[34]  D. Margolis,et al.  Diabetes, Lower-Extremity Amputation, and Death , 2015, Diabetes Care.

[35]  K. Maiese.  New Insights for Oxidative Stress and Diabetes Mellitus , 2015, Oxidative medicine and cellular longevity.

[36]  J. Silvestre,et al.  Diabetes Mellitus and Ischemic Diseases: Molecular Mechanisms of Vascular Repair Dysfunction , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[37]  Jidong Cheng,et al.  High uric acid directly inhibits insulin signalling and induces insulin resistance. , 2014, Biochemical and biophysical research communications.

[38]  S. Tesfaye,et al.  Medical strategies to reduce amputation in patients with Type 2 diabetes , 2013, Diabetic medicine : a journal of the British Diabetic Association.

[39]  Nancy M Albert,et al.  Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.

[40]  S. Yamagishi,et al.  Glucose-dependent Insulinotropic Polypeptide (GIP) Inhibits Signaling Pathways of Advanced Glycation End Products (AGEs) in Endothelial Cells via its Antioxidative Properties , 2012, Hormone and Metabolic Research.

[41]  S. Sivaprasad,et al.  Hypoxia and oxidative stress in the causation of diabetic retinopathy. , 2011, Current diabetes reviews.

[42]  M. Burnett,et al.  Aging Causes Collateral Rarefaction and Increased Severity of Ischemic Injury in Multiple Tissues , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[43]  P. Winocour,et al.  Oxidative stress in early diabetic nephropathy: fueling the fire , 2011, Nature Reviews Endocrinology.

[44]  F. Biasi,et al.  N-acetylcysteine is able to reduce the oxidation status and the endothelial activation after a high-glucose content meal in patients with Type 2 diabetes mellitus , 2009, Journal of endocrinological investigation.

[45]  A. Deshpande,et al.  Epidemiology of Diabetes and Diabetes-Related Complications , 2008, Physical Therapy.

[46]  S. Sharkis,et al.  A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. , 2007, Blood.

[47]  R. Dhiman,et al.  Insulin tolerance test is comparable to homeostasis model assessment for insulin resistance in patients with nonalcoholic fatty liver disease. , 2007, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.

[48]  K. Holzapfel,et al.  Role of focal adhesion kinase (FAK) in renal ischaemia and reperfusion , 2007, Pflügers Archiv - European Journal of Physiology.

[49]  C. Pang,et al.  The effect of N-acetylcysteine on cardiac contractility to dobutamine in rats with streptozotocin-induced diabetes. , 2005, European journal of pharmacology.

[50]  X. Leverve,et al.  Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process. , 2005, Diabetes.

[51]  R. Alexander,et al.  Mechanisms of Reactive Oxygen Species–Dependent Downregulation of Insulin Receptor Substrate-1 by Angiotensin II , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[52]  Alex F Chen,et al.  Gene Therapy of Endothelial Nitric Oxide Synthase and Manganese Superoxide Dismutase Restores Delayed Wound Healing in Type 1 Diabetic Mice , 2004, Circulation.

[53]  O. Cakir,et al.  Neuroprotective Effect of N-Acetylcysteine and Hypothermia on the Spinal Cord Ischemia—Reperfusion Injury , 2003, Cardiovascular surgery.

[54]  F. Marcheselli,et al.  Apoptosis in human aortic endothelial cells induced by hyperglycemic condition involves mitochondrial depolarization and is prevented by N-acetyl-L-cysteine. , 2002, Metabolism: clinical and experimental.

[55]  M. White,et al.  Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action* , 2002, The Journal of Biological Chemistry.

[56]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.

[57]  A. Papavassiliou,et al.  Serine phosphorylation of insulin receptor substrate-1: a novel target for the reversal of insulin resistance. , 2001, Molecular endocrinology.

[58]  Jae Hyun Kim,et al.  Genetic analysis of a new mouse model for non-insulin-dependent diabetes. , 2001, Genomics.

[59]  J. Goldberg,et al.  Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway. , 1999, Diabetes.

[60]  J. Russell,et al.  Identification of Enhanced Serine Kinase Activity in Insulin Resistance* , 1999, The Journal of Biological Chemistry.

[61]  R. Roth,et al.  Modulation of Insulin Receptor Substrate-1 Tyrosine Phosphorylation by an Akt/Phosphatidylinositol 3-Kinase Pathway* , 1999, The Journal of Biological Chemistry.

[62]  R. Rutherford,et al.  Recommended standards for reports dealing with lower extremity ischemia: revised version. , 1997, Journal of vascular surgery.

[63]  Rossella D'Oria,et al.  Oxidative stress and reactive oxygen species in endothelial dysfunction associated with cardiovascular and metabolic diseases. , 2018, Vascular pharmacology.

[64]  M. Vyver,et al.  Intrinsic Mesenchymal Stem Cell Dysfunction in Diabetes Mellitus : Implications for Autologous Cell Therapy , 2017 .

[65]  N. Frangogiannis,et al.  Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities. , 2016, Journal of molecular and cellular cardiology.

[66]  Yen Chang,et al.  Enhancement of cell adhesion, retention, and survival of HUVEC/cbMSC aggregates that are transplanted in ischemic tissues by concurrent delivery of an antioxidant for therapeutic angiogenesis. , 2016, Biomaterials.

[67]  M. Takhtfooladi,et al.  Effects of N-acetylcysteine and pentoxifylline on remote lung injury in a rat model of hind-limb ischemia/reperfusion injury , 2016, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[68]  John V. White,et al.  Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.

[69]  Dhiren P. Shah,et al.  ON OXIDATIVE STRESS AND DIABETIC COMPLICATIONS , 2013 .

[70]  A. Luttun,et al.  Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 , 2002, Nature Medicine.